Print Print
CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.

Halitosis - Management
Basis for recommendation

These recommendations are based on published narrative reviews on halitosis or oral malodour [Rosenberg, 1996; Coventry et al, 2000; Yaegaki and Coil, 2000; Morita and Wang, 2001; Messadi and Younai, 2003; Scully and Felix, 2005a; Porter and Scully, 2006; Lee et al, 2007; Hughes and McNab, 2008; Scully and Greenman, 2008].

  • Smelling the person's breath is recommended to confirm halitosis and to exclude suspected pseudo-halitosis or halitophobia.
    • It is generally recognized that individual assessment is a poor measure of halitosis [Hughes and McNab, 2008; Scully and Greenman, 2008].
    • Because of the difficulty inherent in smelling one's own breath, some people may have exaggerated concerns about their own breath [Rosenberg, 1996; Eli et al, 2001].
    • In a study involving 2000 consecutive people visiting a Dutch multidisciplinary breath odour clinic, 15.7% had no objective signs of malodour and were grouped as pseudo-halitosis/halitophobia [Quirynen et al, 2009].
  • Subjective (organoleptic) assessment is regarded as the most simple, reliable, and practical method for evaluating the severity of halitosis [Yaegaki and Coil, 2000; Porter and Scully, 2006; Scully and Greenman, 2008; Vandekerckhove et al, 2009].
    • Methods such as gas chromatography or measurement of volatile sulphur compounds are more objective and are commonly used in research. However, these methods are impractical, expensive, and unavailable in primary care. The limitations of volatile sulphur compound measurement is discussed in Supporting evidence.

© NHS Institute for Innovation and Improvement